Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingela Wiklund

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
American Journal of Hypertension|October 6, 2005
Felodipine-metoprolol combination tablet: maintained health-related quality of life in the presence of substantial blood pressure reductionBjörn Dahlöf, Alessio Degl' Innocenti, Dag Elmfeldt, et al.
European Heart Journal|June 7, 2014
The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trialsStefan D Anker, Stefan Agewall, Martin Borggrefe, et al.
Journal of Clinical Epidemiology|July 16, 2008
Specific HRQL instruments and symptom scores were more responsive than preference-based generic instruments in patients with GERDJan L Brozek, Gordon H Guyatt, Diane Heels-Ansdell, et al.
Medical Care|December 14, 2004
A randomized multicenter trial to evaluate simple utility elicitation techniques in patients with gastroesophageal reflux diseaseHolger J Schünemann, David Armstrong, Alessio Degl'innocenti, et al.
Health and Quality of Life Outcomes|January 15, 2005
The influence of demographic factors and health-related quality of life on treatment satisfaction in patients with gastroesophageal reflux disease treated with esomeprazoleAlessio Degl' Innocenti, Gordon H Guyatt, Ingela Wiklund, et al.
Pharmacoeconomics|May 10, 2007
The Work Productivity and Activity Impairment Questionnaire for Patients with Gastroesophageal Reflux Disease (WPAI-GERD): responsiveness to change and English language validationPeter Wahlqvist, Gordon H Guyatt, David Armstrong, et al.
BMC Gastroenterology|July 12, 2005
The impact of illness in patients with moderate to severe gastro-esophageal reflux diseaseSamer El-Dika, Gordon H Guyatt, David Armstrong, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
American Journal of Hypertension|October 6, 2005
Felodipine-metoprolol combination tablet: maintained health-related quality of life in the presence of substantial blood pressure reductionBjörn Dahlöf, Alessio Degl' Innocenti, Dag Elmfeldt, et al.
European Heart Journal|June 7, 2014
The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trialsStefan D Anker, Stefan Agewall, Martin Borggrefe, et al.
Journal of Clinical Epidemiology|July 16, 2008
Specific HRQL instruments and symptom scores were more responsive than preference-based generic instruments in patients with GERDJan L Brozek, Gordon H Guyatt, Diane Heels-Ansdell, et al.
Medical Care|December 14, 2004
A randomized multicenter trial to evaluate simple utility elicitation techniques in patients with gastroesophageal reflux diseaseHolger J Schünemann, David Armstrong, Alessio Degl'innocenti, et al.
Health and Quality of Life Outcomes|January 15, 2005
The influence of demographic factors and health-related quality of life on treatment satisfaction in patients with gastroesophageal reflux disease treated with esomeprazoleAlessio Degl' Innocenti, Gordon H Guyatt, Ingela Wiklund, et al.
Pharmacoeconomics|May 10, 2007
The Work Productivity and Activity Impairment Questionnaire for Patients with Gastroesophageal Reflux Disease (WPAI-GERD): responsiveness to change and English language validationPeter Wahlqvist, Gordon H Guyatt, David Armstrong, et al.
BMC Gastroenterology|July 12, 2005
The impact of illness in patients with moderate to severe gastro-esophageal reflux diseaseSamer El-Dika, Gordon H Guyatt, David Armstrong, et al.
Pageof 9